SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015946
Filing Date
2018-11-14
Accepted
2018-11-14 12:47:19
Documents
29
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 227842
2 ex31-1.htm EX-31.1 17330
3 ex32-1.htm EX-32.1 6659
  Complete submission text file 0001493152-18-015946.txt   900722

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lwel-20180930.xml EX-101.INS 85008
5 XBRL SCHEMA FILE lwel-20180930.xsd EX-101.SCH 11870
6 XBRL CALCULATION FILE lwel-20180930_cal.xml EX-101.CAL 17628
7 XBRL DEFINITION FILE lwel-20180930_def.xml EX-101.DEF 29160
8 XBRL LABEL FILE lwel-20180930_lab.xml EX-101.LAB 83236
9 XBRL PRESENTATION FILE lwel-20180930_pre.xml EX-101.PRE 65199
Mailing Address 100 SOUTH SAUNDERS RD, SUITE 150 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD, SUITE 150 LAKE FOREST IL 60045 (847) 574 6288
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 181182091
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1